Ferozsons Laboratories Limited

Amid concern over the availability of sufficient quantities of Gilead Sciences, Inc. ’s remdesivir for treating coronavirus patients in Europe, the company says it is discussing "multiple options" wi

Zydus group's Cadila Healthcare hopes to launch its version of Gilead Sciences ’ investigational COVID-19 drug remdesivir in India by end-July, even as other early licensees Cipla and Hetero Dru

COVID-19 is turning out to be like the board game snakes and ladders, with the drugs seen as potential treatments being the players and clinical trials the snakes. After the UK Recovery trial, run by

Zydus group's Cadila Healthcare Ltd. hopes to launch its version of Gilead Sciences Inc. ’s investigational COVID-19 drug remdesivir in India by end-July, even as other early licensees Cipla Ltd.